1044cd

    On page 2, line 22, of the printed bill, delete "United States".

    On page 2, line 22, overstrike "Food and Drug".

    On page 2, overstrike line 23.

    On page 2, line 24, overstrike everything before ";" and insert "DSCSA".

    On page 7, line 24, overstrike everything before "persons" and insert "As used in this chapter, the term, distribution, means the sale, purchase, trade, delivery, handling, storage, or receipt of a product".

    On page 8, line 1, delete everything before "." and insert "other than a consumer or patient".

    On page 12, line 5, overstrike "wholesale".

    On page 13, line 8, overstrike everything after "person" and insert "other than a manufacturer, a manufacturer's co-licensed partner, a third-party logistics provider or repackager, engaged in wholesale distribution".

    On page 13, overstrike lines 9 to 11, inclusive.

    On page 13, delete line 12, and insert "wholesale drug traders; speciality wholesale distributors; third party logistics providers; retail".

    On page 13, overstrike lines 13 and 14.

    On page 13, delete line 15, and insert "normal distribution channel such wholesale distributor must also be an authorized".

    On page 13, line 16, overstrike everything before "." .

    On page 16, delete lines 1 to 21, inclusive, and insert:

"    Section 21. That § 36-11A-39 be repealed.

    36-11A-39. Each person who is engaged in wholesale distribution of prescription drugs, including repackagers, but excluding the original manufacturer of the finished form of the prescription drug that leave, or have ever left, the normal distribution channel shall, before each wholesale distribution of such drug, provide a pedigree to the person who receives such drug.

    A retail pharmacy or chain pharmacy warehouse shall comply with the requirements of this section only if the pharmacy or chain pharmacy warehouse engages in wholesale distribution of prescription drugs, as defined in § 36-11A-26.

---

    Section 22. That § 36-11A-40 be repealed.

    36-11A-40. The board shall determine by July 1, 2009, a targeted implementation date for electronic track and trace pedigree technology. Such a determination shall be based on consultation with manufacturers, distributors, and pharmacies responsible for the sale and distribution of prescription drug products in this state. After consultation with interested stakeholders and prior to implementation of the electronic pedigree, the board shall determine that the technology is universally available across the entire prescription pharmaceutical supply chain. The implementation date for the mandated electronic track and trace pedigree technology shall be no sooner than July 1, 2010, and may be extended by the board in one year increments if it appears the technology is not universally available across the entire prescription pharmaceutical supply chain. ".